bezorging-wit
Shipping within 1-2 days
klantenservice-wit
Expert customer service
essentiele-olien-wit
Human-grade, organic products
getest-wit
Scientifically proven ingredients
bezorging-wit
Shipping within 1-2 days
klantenservice-wit
Expert customer service
essentiele-olien-wit
Human-grade, organic products
getest-wit
Scientifically proven ingredients
bezorging-wit
Shipping within 1-2 days
klantenservice-wit
Expert customer service
essentiele-olien-wit
Human-grade, organic products
getest-wit
Scientifically proven ingredients

Biofilm Balance

NGD Care — Scientific background to food supplements

Biofilm Balance:
the science behind biofilm degradation in the gut

Why is pathogenic biofilm so persistent? How do NAC, lactoferrin and digestive enzymes work complementary in breaking biofilm structures in the gut? Substantiated with recent literature.

By Stefan Veenstra DVM

Biofilm: the hidden engine behind chronic intestinal complaints

Biofilm is not a peculiarity of hospital infections or wound infections. It is a normal and ubiquitous phenomenon in the intestines of dogs and cats. In a healthy gut ecosystem, a biofilm also exists, but as a structured commensal community that protects the gut wall. However, in dysbiosis, pathogenic species can form predominant biofilm structures that colonize the gut wall, produce toxins, and keep the microbiome structurally unbalanced. [1]

The extracellular matrix (ECM) of biofilm consists of a complex mix of polysaccharides (such as alginate and cellulose), proteins, extracellular DNA and lipids. This matrix acts as a physical and chemical shield: it protects the trapped microorganisms from the immune system, antimicrobials and antibiotics. Bacteria in a pathogenic biofilm are up to 1000 times more resistant to antibiotics than bacteria of the same species that do not live in a biofilm. [2]

Biofilm is not one structure but a dynamic, layered system. An effective approach requires multiple mechanisms acting on different layers of the matrix. A single intervention is structurally insufficient.

How biofilm maintains chronic complaints

Pathogenic biofilm in the gut is more than a passive shield. The enclosed microorganisms are metabolically active and continuously produce:

Toxins and metabolitesBacterial toxins and fungal metabolites damage the intestinal epithelium, increase intestinal permeability, and cause low-grade systemic inflammation via LPS leakage.
Quorum sensing signalsBacteria communicate via quorum sensing molecules to coordinate and strengthen their biofilm structure. Biofilm is therefore a self-organizing and reinforcing structure.
Immune system evasionBiofilm actively modulates local immune responses by inhibiting macrophage phagocytosis and weakening neutrophil activity, preventing the immune system from effectively clearing the infection.
Persistence and recolonizationWhen conditions deteriorate, microorganisms can leave the biofilm and colonize new locations in the gut, which explains relapse after treatment.

The three components of Biofilm Balance

NAC: Biofilm Matrix Degradation and Glutathione Repair

N-acetylcysteine (NAC) is the best-documented biofilm disruptor in the microbiological literature. The primary mechanism is mucolytic: NAC breaks down disulfide bridges in the protein component of the extracellular matrix, which destabilizes the viscoelastic structure of the biofilm and exposes the trapped microorganisms. [3] A systematic review of Dinicola et al. documented significant biofilm reduction in multiple pathogenic species following NAC treatment, including Pseudomonas aeruginosa, Staphylococcus aureus , and Candida albicans. [4]

In addition to its direct biofilm action, NAC is an essential precursor of glutathione (GSH), the most abundant intracellular antioxidant. With chronic biofilm loading, GSH levels in liver and immune cells are systematically reduced due to the high oxidative load of continuous immune activation. NAC restores the GSH pool, allowing macrophages and neutrophils to regain their phagocytic capacity and the liver to more effectively process the toxins released during biofilm degradation. [5]

Lactoferrin: iron sequestration, membrane disruption and biofilm inhibition

Lactoferrin is a multifunctional glycoprotein of the innate immune system with a particularly broad anti-biofilm profile that acts through multiple mechanisms at the same time. A review in Frontiers in Cellular and Infection Microbiology (2025) describes the two primary mechanisms of action: iron chelation and membrane disruption via binding to lipopolysaccharide (LPS) from gram-negative bacteria. [6]

Iron is an essential growth factor for most pathogenic microorganisms and plays a direct role in the initiation of biofilm formation. By sequestering iron, lactoferrin inhibits bacterial growth as well as the establishment of new biofilm. Khanum et al. (2023) showed that lactoferrin in vitro both preventively inhibits biofilm formation and actively destabilizes existing biofilms in methicillin-resistant staphylococci, through a mechanism independent of direct bactericidal action. [7]

A clinically important advantage of lactoferrin over NAC is its selectivity profile. Lactoferrin inhibits Enterobacteriaceae and pathogenic species but stimulates commensal Lactobacillus and Bifidobacterium species. This makes it the only component in Biofilm Balance with an active differentiation between pathogenic and commensal. [8]

NAC and lactoferrin: complementary biofilm mechanisms

NAC breaks the protein structure of the biofilm matrix via disulfide bridge degradation. Lactoferrin inhibits iron-dependent biofilm formation and destabilizes existing biofilms via LPS binding and membrane disruption. Together, they cover two fundamentally different layers of the biofilm architecture: the protein matrix and the iron-dependent biofilm initiation. As a result, the combination is mechanistically significantly more effective than each individual.

Amylase, protease and lipase: enzymatic matrix degradation

The extracellular matrix of biofilm consists of three macromolecular classes: polysaccharides (carbohydrates), proteins and lipids, in variable proportions depending on the species involved. Targeted enzymatic degradation of each of these components makes the matrix progressively more porous and accessible to the other active components and the immune system. [9]

Amylase breaks down the polysaccharide component that forms the structural backbone of most biofilms. Protease breaks down the protein component that mediates biofilm adhesion to the intestinal epithelium, adjoining the disulfide bridge degradation of NAC. Lipase breaks down the lipid protective layer of species such as Candida albicans that use specialized lipids for biofilm protection. The three enzymes together provide broad enzymatic coverage over the entire macromolecular composition of the biofilm matrix.

The Herxheimer response: why support is necessary

Effective biofilm breakdown releases toxins, endotoxins, and bacterial fragments that the body must process. In the case of rapid or massive biofilm degradation, this can lead to a temporary worsening of symptoms: the Herxheimer or Jarisch-Herxheimer reaction. This is not a side effect of the supplement but a sign that it is working. The toxic burden temporarily exceeds the processing capacity of the liver and immune system. [10]

To prevent or limit this, Biofilm Balance is intended solely as part of an integral gut recovery protocol, not as a standalone intervention. The NGD Care Gut Protocol combines Biofilm Balance with Chlorella-Spirulina-Alfalfa for hepatic toxin clearance, Liposomal Curcumin for inhibition of the inflammatory response on toxin release, Liposomal Vitamin C as antioxidant support, and Prebiotics as microbiome preparation for the build-up phase.

Important: always part of an integral protocol

Biofilm Balance is not a standalone supplement. Always use in combination with liver, intestinal and immune system support agents. If in doubt about dosage, pace of introduction or support: consult an (integrative) veterinarian. The NGD Care Bowel Protocol provides the complete protocol environment for safe and effective application.

Application area Biofilm Balance

Chronic gut dysbiosis with signs of biofilm load. Recurrent intestinal infections where standard treatment does not work sufficiently. Candida overgrowth and fungal dysbiosis in the intestine. Skin problems, itching and ear infections with an intestinal component. Low-grade inflammation and increased intestinal permeability. Always as a phase 1 component of the NGD Care Gut Protocol, not standalone. In consultation with an (integrative) veterinarian.

Conclusion

Biofilm Balance combines three mechanistically complementary biofilm interventions: NAC for protein matrix degradation and glutathione repair, lactoferrin for iron sequestration, membrane disruption and selective biofilm inhibition, and enzymes for broad enzymatic matrix degradation across all macromolecular classes. The combination tackles biofilm architecture on three different levels at the same time.

Biofilm Balance is mechanistically one of the most thoughtful biofilm interventions in the NGD Care range, but requires a protocol context with adequate liver support, antioxidant protection and microbiome build-up for safe and sustainable operation. Always in consultation with an (integrative) veterinarian.

View Biofilm Balance in the NGD Care webshop

To the product page

Literature

  1. Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010; 8(9):623–633.
  2. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004; 2(2):95–108.
  3. Zhao T, Liu Y. N-acetylcysteine inhibits biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 2010;10:140.
  4. Dinicola S, De Grazia S, Carlomagno G, Pintucci JP. N-acetylcysteine as powerful molecule to destroy bacterial biofilms. A systematic review. Eur Rev Med Pharmacol Sci. 2014; 18(19):2942–2948.
  5. Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009; 30(1–2):1–12.
  6. Xander C, Martinez EE, Toothman RG, et al. Treatment of bacterial biothreat agents with a novel purified bioactive lactoferrin affects both growth and biofilm formation. Front Cell Infect Microbiol. 2025. doi:10.3389/fcimb.2025.1603689. [Most recent review lactoferrin anti-biofilm 2025]
  7. Khanum R, Chung PY, Clarke SC, Chin BY. Lactoferrin modulates the biofilm formation and bap gene expression of methicillin-resistant Staphylococcus epidermidis. Can J Microbiol. 2023; 69(2):117–122.
  8. Vera-Chamorro JF, Higuera-de la Tijera MF, Vargas-Flores E, et al. Lactoferrin and lactoferricin B reduce adhesion and biofilm formation in intestinal symbionts Bacteroides fragilis and Bacteroides thetaiotaomicron. Microb Pathog. 2020;147:104419.
  9. Thallinger B, Prasetyo EN, Nyanhongo GS, Guebitz GM. Antimicrobial enzymes: an emerging strategy to fight microbes and microbial biofilms. Biotechnol J. 2013; 8(1):97–109.
  10. Pound MW, May DB. Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions. J Clin Pharm Ther. 2005; 30(3):291–295.

This information is educational in nature and based on available scientific literature. The studies mentioned are not always directly veterinary or specific to the formulation described here. This text does not replace a veterinary consultation and does not contain any therapeutic claims.

Item added to cart.
0 items -  0,00